Study wrapper · #1290
Body Composition and Lifestyle Interventions in Pharmacological Treatment of Acquired Hypothalamic Obesity: A Systematic Review of Randomized Controlled Trials.
Editor's note
Seven small randomized trials, combined descriptively because they were too heterogeneous to pool, with GRADE certainty rated low for anthropometric, metabolic and behavioral outcomes. The semaglutide result is directionally consistent but rests on a handful of participants in a rare condition, and the reviewers flag that lean-mass assessment was inadequate across the whole literature. Read it as an early signal for a population with few options, not as evidence of comparative superiority over the other agents reviewed.
Plain-language abstract
This systematic review gathered seven randomized trials of drug and lifestyle approaches to obesity caused by damage to the hypothalamus, often following brain tumor therapy. Semaglutide produced sustained weight loss in the trials that included it, while other agents gave mixed or limited results. The reviewers rated the overall certainty of the body-composition evidence as low.